Testing effectiveness (Phase 2)Active Not RecruitingNCT03326336
What this trial is testing
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
Who this might be right for
Non-syndromic Retinitis Pigmentosa
GenSight Biologics 10